Project Details
Short title | TORCH: Phase II study to determine the safety and efficacy of the dual mTORC inhibitor AZD2014 and to investigate additional toxicities in combination with rituximab in relapsed refractory DLBCL |
---|---|
Status | Finished |
Effective start/end date | 1/08/15 → 31/03/21 |
Funding
- BLOODWISE
- ASTRA ZENECA UK LIMITED